Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease (Q41253542)
scientific article
Language:
Current Data About Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease
(P31) (Q13442814)
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

(P304) 106-110
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

(P407) (Q1860)

(P433) 1
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

(P478) 93
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

(P577) Monday, January 1, 1996
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

(P921) (Q372016)

(Q12174)

(Q389735)
(P887)

(Q107129060)
(P887)

(P1433) (Q578091)
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

(P1476) "Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease" (language: en)
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

(P2093) Lundgren CH
(P1545) 1
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

Brown SL
(P1545) 2
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

Nordt TK
(P1545) 3
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

Sobel BE
(P1545) 4
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

Fujii S
(P1545) 5
(P248)
(P698) 8616916
(P813) Thursday, September 28, 2017

other details
description scientific article

External Links
(P356) 10.1161/01.CIR.93.1.106
(P698) 8616916